GNA13 mutation

CI-VAR-00004998Explore in graph →CIViC 4759

Curated evidence

Evidence by cancer (3 items)

Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.

civicCuratedShowing 1–3 of 3 evidence items across 2 cancer contexts on this page · levels, directions and significance as curated at the source; each row links to its CIViC record.

Molecular profile	Therapy	Type	Level	Direction · significance	Rating (1–5)	Status	Evidence	Source
Burkitt Lymphoma1
GNA13 mutation	(oncogenic)	Oncogenic	E	Supports Oncogenicity	3	submitted	EID11821 Mutations in this gene have been described in several genome-wide studies of B-cell lymphomas including this one PMID 30617194 · Grande et al., 2019 · Open in CIViC	civic
Diffuse Large B-Cell Lymphoma2
GNA13 mutation	(oncogenic)	Oncogenic	E	Supports Oncogenicity	3	submitted	EID11820 Somatic mutations in this gene have been reported in several genome-wide studies of B-cell lymphomas PMID 30275490 · Arthur et al., 2018 · Open in CIViC	civic
GNA13 mutation

ClinVar

Clinical significance (0)

ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.

Data not yet available

No ClinVar interpretation attached to this variant.